1-(tert-Butoxycarbonyl)-4-(2-(trifluoromethyl)phenyl)piperidine-4-carboxylic acid

Catalog No.: 
ACRNCU534
CAS No.: 
1211534-42-7
Molecular Formula: 
C18H22F3NO4
Molecular Weight: 
373.37
1-(tert-Butoxycarbonyl)-4-(2-(trifluoromethyl)phenyl)piperidine-4-carboxylic acid structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
50mg99%$320.00InquiryInquiry
100mg99%$485.00InquiryInquiry
250mg99%$949.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name1-(tert-Butoxycarbonyl)-4-(2-(trifluoromethyl)phenyl)piperidine-4-carboxylic acid
IUPAC Name1-(tert-butoxycarbonyl)-4-(2-(trifluoromethyl)phenyl)piperidine-4-carboxylic acid
Molecular FormulaC18H22F3NO4
Molecular Weight373.37
SMILESO=C(C1(C2=CC=CC=C2C(F)(F)F)CCN(C(OC(C)(C)C)=O)CC1)O
InChI KeyUZXZGDYNTTYYLC-UHFFFAOYSA-N
Synonym1-(tert-Butoxycarbonyl)-4-[2-(trifluoromethyl)phenyl]piperidine-4-carboxylic aci;1,4-Piperidinedicarboxylic acid, 4-[2-(trifluoromethyl)phenyl]-, 1-(1,1-dimethylethyl) ester;1-(1,1-Dimethylethyl) 4-[2-(trifluoromethyl)phenyl]-1,4-piperidinedicarboxylate
CAS No.1211534-42-7

Synthetic Route by SureRoute

1. ACRNCU534 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACRNCU534 route product structure diagram
    ACRNCU5341211534-42-7
Inquiry

2. ACRNCU534 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACRNCU534 route product structure diagram
    ACRNCU5341211534-42-7
Inquiry

3. ACRNCU534 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACRNCU534 route product structure diagram
    ACRNCU5341211534-42-7
Inquiry

Comments (0)